Company Filing History:
2 out of 2 
2 out of 2 
2 out of 282 
Years Active: 2024-2025
Title: Innovations in Cancer Detection by Johannes Eichner
Introduction
Johannes Eichner is a notable inventor based in Lörrach, Germany. He has made significant contributions to the field of cancer detection through his innovative research and patented methods. With a total of 2 patents, his work focuses on the development of epigenetic markers that can aid in the diagnosis and management of certain cancers.
Latest Patents
Eichner's latest patents include groundbreaking methods for determining the presence or absence of certain cancers in individuals. His invention specifically addresses ovarian cancer in women, utilizing the detection of methylated and un-methylated CpGs associated with differentially methylated regions (DMRs). These methods have diagnostic, prognostic, and predictive utility, allowing for better management of cancer therapies. The invention also encompasses nucleic acids that can be detected during the method, as well as related compositions and kits that facilitate the application of these innovative techniques.
Career Highlights
Throughout his career, Johannes Eichner has worked with prominent companies in the genomics and biotechnology sectors. Notably, he has been associated with Eurofins Genomics Europe Sequencing GmbH and Genedata AG. His experience in these organizations has contributed to his expertise in the field of cancer research and diagnostics.
Collaborations
Eichner has collaborated with esteemed colleagues such as Martin Widschwendter and Allison Jones. These partnerships have further enhanced his research and development efforts in cancer detection technologies.
Conclusion
Johannes Eichner's contributions to cancer detection through his innovative patents highlight the importance of research in improving diagnostic methods. His work continues to pave the way for advancements in the management of cancer, particularly ovarian cancer.